Importantly, given the general lack of matching tumor tissue for biomarker analysis at the CRPC stage these methods have been used to successfully detect AR-V7 transcripts from liquid biopsies, such as urine, plasma, exosomes and circulating tumor cells (CTCs) with the most reliable data originating from AR-V7 analysis in CTCs11. This evidence concerns the gene AR and neoplasm.